VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 147 filers reported holding VIKING THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $206,612 | +217.9% | 21,980 | -8.3% | 0.06% | +216.7% |
| Q3 2022 | $65,000 | -5.8% | 23,980 | 0.0% | 0.02% | -5.3% |
| Q2 2022 | $69,000 | -4.2% | 23,980 | 0.0% | 0.02% | +18.8% |
| Q1 2022 | $72,000 | -34.5% | 23,980 | 0.0% | 0.02% | -38.5% |
| Q4 2021 | $110,000 | -63.3% | 23,980 | -50.0% | 0.03% | -18.8% |
| Q3 2021 | $300,000 | +106.9% | 47,960 | +100.0% | 0.03% | -22.0% |
| Q2 2021 | $145,000 | +35.5% | 23,980 | +26.0% | 0.04% | +5.1% |
| Q4 2020 | $107,000 | -3.6% | 19,030 | 0.0% | 0.04% | -17.0% |
| Q3 2020 | $111,000 | -15.3% | 19,030 | +4.4% | 0.05% | -26.6% |
| Q2 2020 | $131,000 | +8.3% | 18,230 | -29.5% | 0.06% | -22.0% |
| Q1 2020 | $121,000 | -41.5% | 25,870 | 0.0% | 0.08% | -30.5% |
| Q4 2019 | $207,000 | +16.3% | 25,870 | 0.0% | 0.12% | +9.3% |
| Q3 2019 | $178,000 | -17.2% | 25,870 | 0.0% | 0.11% | -24.5% |
| Q2 2019 | $215,000 | -16.3% | 25,870 | 0.0% | 0.14% | +38.8% |
| Q1 2019 | $257,000 | +29.8% | 25,870 | 0.0% | 0.10% | -29.9% |
| Q4 2018 | $198,000 | -37.7% | 25,870 | -10.9% | 0.15% | -29.0% |
| Q3 2018 | $318,000 | +174.1% | 29,020 | +136.9% | 0.21% | +143.5% |
| Q2 2018 | $116,000 | +118.9% | 12,248 | +1.7% | 0.08% | +112.5% |
| Q1 2018 | $53,000 | +20.5% | 12,048 | +11.8% | 0.04% | +8.1% |
| Q4 2017 | $44,000 | – | 10,778 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |